Versiti Acquires Ethical and Independent Review Services (E&I)

Versiti Acquires Pearl Pathways

November 7, 2023

Healthcare Services

Versiti, a Milwaukee-based blood health organization, has acquired Pearl Pathways, an Indianapolis-area life science consulting firm that provides regulatory affairs, quality compliance, CRO services and an independent IRB. The acquisition expands Versiti's clinical trial and life-sciences service capabilities, enabling earlier and deeper support for product development across biopharmaceutical, medical device, and diagnostics clients.

Versiti Acquires Quantigen

July 10, 2023

Healthcare Services

Versiti, a national blood health organization headquartered in Milwaukee, has acquired Quantigen, a specialty laboratory and contract research organization based in Fishers, Indiana. The acquisition expands Versiti’s clinical-trials and diagnostic capabilities—adding assay development, biomarker validation, and regulatory support for preclinical and clinical research.

Sabai Group Acquires Alpha Independent Review Board (Alpha IRB)

January 10, 2024

Healthcare Services

Sabai Group LLC, a provider of biosafety and human research protection services, has acquired Alpha Independent Review Board, LLC (Alpha IRB), an AAHRPP-accredited IRB headquartered in San Clemente, California. The acquisition expands Sabai's institutional review capabilities and integrates Alpha IRB's late-stage multi-center review expertise into Sabai's IRB, IBC, and cell/gene therapy service offerings; Alpha IRB founder Marianne Thornton joins Sabai's board.

Advarra Acquires IntegReview IRB

November 9, 2020

Healthcare Services

Advarra has acquired IntegReview IRB, an AAHRPP-accredited central IRB based in Austin, Texas. The acquisition expands Advarra's IRB and early-phase clinical research capabilities, establishes its first office in the southern U.S., and will be integrated into Advarra over approximately six months.

Verista Acquires ILB Enterprises

May 31, 2024

Healthcare Services

Verista has acquired ILB Enterprises, a New Jersey–based life sciences consulting firm specializing in pharmacovigilance, safety compliance, program and project management. The deal, led by Verista's private equity sponsor Lightview Capital, expands Verista's capabilities across compliance, automation and validation and strengthens its Mid‑Atlantic life sciences services footprint.

ICV Partners Acquires Environmental Remedies (ERI)

January 27, 2025

Environmental Services

ICV Partners has acquired a significant ownership interest in Environmental Remedies, LLC (ERI), a California-based residential asbestos abatement service provider. ICV will support ERI's growth through infrastructure investment, leadership development, geographic expansion and acquisitions, with financing provided by Stellus Capital Management.